rs117038427

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017882.3(CLN6):​c.298-6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00839 in 1,613,084 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0061 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0086 ( 82 hom. )

Consequence

CLN6
NM_017882.3 splice_region, intron

Scores

3
Splicing: ADA: 0.005652
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.79

Publications

4 publications found
Variant links:
Genes affected
CLN6 (HGNC:2077): (CLN6 transmembrane ER protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]
CLN6 Gene-Disease associations (from GenCC):
  • ceroid lipofuscinosis, neuronal, 6A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine, Myriad Women's Health, G2P, Orphanet
  • ceroid lipofuscinosis, neuronal, 6B (Kufs type)
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017882.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 15-68211869-G-A is Benign according to our data. Variant chr15-68211869-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128785.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00608 (926/152244) while in subpopulation EAS AF = 0.0319 (165/5172). AF 95% confidence interval is 0.0279. There are 4 homozygotes in GnomAd4. There are 427 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017882.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
NM_017882.3
MANE Select
c.298-6C>T
splice_region intron
N/ANP_060352.1Q9NWW5-1
CLN6
NM_001411068.1
c.394-6C>T
splice_region intron
N/ANP_001397997.1Q9NWW5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
ENST00000249806.11
TSL:1 MANE Select
c.298-6C>T
splice_region intron
N/AENSP00000249806.5Q9NWW5-1
CLN6
ENST00000637667.1
TSL:1
c.199-6C>T
splice_region intron
N/AENSP00000489843.1A0A1B0GTU6
CLN6
ENST00000566347.5
TSL:1
c.298-551C>T
intron
N/AENSP00000457783.1H3BUT1

Frequencies

GnomAD3 genomes
AF:
0.00609
AC:
927
AN:
152126
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00174
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.0318
Gnomad SAS
AF:
0.00994
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00773
Gnomad OTH
AF:
0.00909
GnomAD2 exomes
AF:
0.00770
AC:
1923
AN:
249610
AF XY:
0.00810
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00350
Gnomad ASJ exome
AF:
0.00728
Gnomad EAS exome
AF:
0.0310
Gnomad FIN exome
AF:
0.000996
Gnomad NFE exome
AF:
0.00688
Gnomad OTH exome
AF:
0.00608
GnomAD4 exome
AF:
0.00863
AC:
12603
AN:
1460840
Hom.:
82
Cov.:
32
AF XY:
0.00859
AC XY:
6245
AN XY:
726634
show subpopulations
African (AFR)
AF:
0.00122
AC:
41
AN:
33474
American (AMR)
AF:
0.00344
AC:
154
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00846
AC:
221
AN:
26124
East Asian (EAS)
AF:
0.0353
AC:
1403
AN:
39694
South Asian (SAS)
AF:
0.0112
AC:
969
AN:
86236
European-Finnish (FIN)
AF:
0.000908
AC:
48
AN:
52858
Middle Eastern (MID)
AF:
0.00270
AC:
15
AN:
5554
European-Non Finnish (NFE)
AF:
0.00832
AC:
9248
AN:
1111844
Other (OTH)
AF:
0.00835
AC:
504
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
613
1226
1840
2453
3066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00608
AC:
926
AN:
152244
Hom.:
4
Cov.:
32
AF XY:
0.00574
AC XY:
427
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00173
AC:
72
AN:
41536
American (AMR)
AF:
0.00340
AC:
52
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.0319
AC:
165
AN:
5172
South Asian (SAS)
AF:
0.00974
AC:
47
AN:
4826
European-Finnish (FIN)
AF:
0.000943
AC:
10
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00773
AC:
526
AN:
68012
Other (OTH)
AF:
0.00900
AC:
19
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00657
Hom.:
3
Bravo
AF:
0.00637
Asia WGS
AF:
0.0180
AC:
62
AN:
3478
EpiCase
AF:
0.00654
EpiControl
AF:
0.00688

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
-
2
not provided (2)
-
-
1
Ceroid lipofuscinosis, neuronal, 6A;C5561927:Ceroid lipofuscinosis, neuronal, 6B (Kufs type) (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
13
DANN
Benign
0.85
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0057
dbscSNV1_RF
Benign
0.068
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs117038427;
hg19: chr15-68504207;
COSMIC: COSV51117630;
COSMIC: COSV51117630;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.